S&Co Inc Agios Pharmaceuticals, Inc. Transaction History

S&Co Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$29.58 - $49.78 $177,480 - $298,680	-6,000 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$44.23 - $57.5 $265,380 - $345,000	6,000 New	6,000 $309,000
Q2 2019 Jul 23, 2019	SELL	$46.17 - $68.1 $156,978 - $231,539	-3,400 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$45.92 - $67.67 $156,128 - $230,078	3,400 New	3,400 $229,000
Q4 2018 Jan 29, 2019	SELL	$42.73 - $76.53 $145,282 - $260,202	-3,400 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$59.83 - $86.53 $203,422 - $294,202	3,400 New	3,400 $278,000
Q4 2017 Jan 22, 2018	SELL	$52.12 - $72.33 $177,208 - $245,922	-3,400 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$54.89 - $67.12 $186,626 - $228,208	3,400	3,400 $227,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.94B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of S&Co Inc, based on Form 13F filings with the SEC.

Stay updated on S&Co Inc with notifications on news.